Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
GLP-1-driven vitamin deficiency linked to rare brain disorder: Study
2+ hour, 51+ min ago (195+ words) (NewsNation) — A new study found that a rare but serious brain condition has been identified in a small number of people taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound. Wernicke encephalopathy is a rare neurological disorder caused…...
FDA Approves Isembyld, First SMA Treatment To Target Muscle Loss
43+ min ago (421+ words) A newly approved treatment for spinal muscular atrophy is moving toward U.S. availability, giving eligible children and adults an additional option to address muscle weakness. Scholar Rock announced September 11 that the Food and Drug Administration approved Isembyld, also known as apitegromab-mstn....
KFSH Conducts Nearly Half of Saudi Arabia's Registered Clinical Trials as Research Infrastructure Expands
1+ hour, 18+ min ago (105+ words) EIN Presswire There were 180 press releases posted in the last 24 hours and 485,982 in the last 365 days. KFSH Conducts Nearly Half of Saudi Arabia's Registered Clinical Trials as Research Infrastructure Expands EIN Presswire provides this news content "as is" without warranty…...
Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder
1+ hour, 32+ min ago (540+ words) Researchers are warning about a rare but potentially life-threatening brain condition that may be linked to popular GLP-1 weight-loss medications. A new study, published in Clinical Nutrition, identified 15 reported cases of Wernicke encephalopathy, a neurological disorder caused by severe vitamin…...
Patients duped as fake pharmacies sell counterfeit weight-loss drugs
1+ hour, 43+ min ago (55+ words) The Times Patients duped as fake pharmacies sell counterfeit weight-loss drugs British regulators admit playing ‘whack-a-mole’ against organised criminals as thousands of illegal sellers use AI to push dangerous medication £1 for 3 months Enjoy unlimited access to all articles. Ends soon....
The Hills’ Lo Bosworth Had Ear Surgery After Otosclerosis Battle ‘Got Way Worse’ During Pregnancy
1+ hour, 13+ min ago (429+ words) The Hills alum Lo Bosworth is opening up about her recovery after undergoing inner ear surgery. “I had surgery on my inner ear yesterday and the recovery has not been as easy as I thought it was going to be,…...
Cefepime Linked to Higher Mortality Risk Than Other Beta-Lactams: Study
3+ hour, 47+ min ago (54+ words) Ten Years to Dapagliflozin Metformin FDC Approval in India - 10 Key Points to Revisit Overcoming the Challenge of Maintaining Weight Reduction Sympathetic Overactivity: The Driver of Hypertension in Young Indians India's Medical Startups: From Innovation to Impact - Prof. (Dr) Yogendra Kumar…...
Al-Knawy: Riyadh Global Medical Biotechnology Summit 2026 Puts Saudi Arabia in Global Spotlight for Medical Biotechnology, Industry
1+ hour, 21+ min ago (330+ words) Riyadh, September 13, 2026, SPA -- Chief Executive Officer of the Ministry of National Guard Health Affairs (MNGHA) Bandar bin Abdulmohsen Al-Knawy expressed his thanks and appreciation to His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime…...
Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial (SMMT:NASDAQ)
1+ hour, 24+ min ago (64+ words) Seeking Alpha nopparit/iStock via Getty Images Summit Therapeutics (SMMT) on Sunday said ivonescimab significantly extended survival compared with Merck’s (MRK) Keytruda in a late-stage lung cancer trial conducted by its partner Akeso (AKESF) in China. Ivonescimab reduced the risk…...
Study raises concerns about GLP-1: Possible link to depression and suicidal thoughts
10+ hour, 9+ min ago (657+ words) GLP-1 weight loss drugs may be linked to a higher risk of depression and suicidal thoughts, especially in people who regain the weight they lost after using them, a new study from South Korea suggests. Researchers analyzed mental health data…...